$DATS
DatChat, Inc. Stock $dats

$dats Overview Financials Valuation SEC Filings Company Website

2024 Q1 Form 10-K Financial Statement

#000121390024027991 Filed on March 29, 2024

Income Statement

Concept	2024 Q1	2023 Q4	2023
Revenue	$131.00	$170.00	$670.00
YoY Change	-14.94%	-95.66%	-98.55%
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin	$1.430M	$1.098M	$7.366M
YoY Change	-32.45%	-53.01%	-30.17%
% of Gross Profit
Research & Development	$233.9K	$287.4K	$1.351M
YoY Change	-32.51%	12.25%	162.43%
% of Gross Profit
Depreciation & Amortization	$5.782K	$8.250K	$28.94K
YoY Change	0.03%	-86.31%	-77.3%
% of Gross Profit
Operating Expenses	$1.664M	$1.385M	$8.718M
YoY Change	380.0%	-46.56%	1592.89%
Operating Profit	-$1.663M		-$8.784M
YoY Change	-33.1%		-28.16%
Interest Expense	$101.5K	$138.7K	$336.3K
YoY Change	-622.44%	119.19%
% of Operating Profit
Other Income/Expense, Net	$101.6K	-$63.80K	$42.74K
YoY Change	16.66%		-51.52%
Pretax Income	-$1.562M	-$1.354M	-$8.405M
YoY Change	-34.9%	-61.69%	-30.76%
Income Tax
% Of Pretax Income
Net Earnings	-$1.138M	-$1.354M	-$8.405M
YoY Change	-52.58%	-61.69%	-30.76%
Net Earnings / Revenue	-868558.78%	-796441.18%	-1254473.13%
Basic Earnings Per Share	-$0.56		-$4.14
Diluted Earnings Per Share	-$0.56	-$0.72	-$4.14
COMMON SHARES
Basic Shares Outstanding	3.009M shares	2.103M shares	2.029M shares
Diluted Shares Outstanding	2.806M shares		2.029M shares

Balance Sheet

Concept	2024 Q1	2023 Q4	2023
SHORT-TERM ASSETS
Cash & Short-Term Investments	$6.086M	$6.190M	$6.190M
YoY Change	-43.86%	-51.42%	-51.42%
Cash & Equivalents	$250.0K	$953.4K
Short-Term Investments	$5.836M	$5.237M	$5.237M
Other Short-Term Assets	$230.5K	$185.7K	$185.7K
YoY Change	-9.26%	37.8%	37.8%
Inventory
Prepaid Expenses	$230.5K	$185.7K
Receivables	$200.00	$180.00	$180.00
Other Receivables	$0.00	$0.00	$0.00
Total Short-Term Assets	$6.317M	$6.376M	$6.376M
YoY Change	-43.07%	-50.48%	-50.48%
LONG-TERM ASSETS
Property, Plant & Equipment	$50.78K	$130.5K	$130.5K
YoY Change	-31.29%	63.8%	-39.06%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets		$0.00	$0.00
YoY Change		-100.0%	-100.0%
Total Long-Term Assets	$107.6K	$130.5K	$130.5K
YoY Change	-44.63%	-45.06%	-45.06%
TOTAL ASSETS
Total Short-Term Assets	$6.317M	$6.376M	$6.376M
Total Long-Term Assets	$107.6K	$130.5K	$130.5K
Total Assets	$6.425M	$6.507M	$6.507M
YoY Change	-43.1%	-50.38%	-50.38%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$384.5K	$322.8K	$322.8K
YoY Change	-14.67%	-20.23%	-20.23%
Accrued Expenses	$64.30K	$83.67K	$83.67K
YoY Change	-9.65%	24.25%	24.25%
Deferred Revenue	$162.00	$118.00
YoY Change	20.0%	-36.56%
Short-Term Debt	$0.00	$0.00	$0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities	$448.9K	$406.6K	$406.6K
YoY Change	-13.98%	-14.13%	-14.13%
LONG-TERM LIABILITIES
Long-Term Debt	$0.00	$0.00	$0.00
YoY Change
Other Long-Term Liabilities		$0.00	$0.00
YoY Change		-100.0%	-100.0%
Total Long-Term Liabilities	$0.00	$0.00	$0.00
YoY Change	-100.0%	-100.0%	-100.0%
TOTAL LIABILITIES
Total Short-Term Liabilities	$448.9K	$406.6K	$406.6K
Total Long-Term Liabilities	$0.00	$0.00	$0.00
Total Liabilities	$448.9K	$406.6K	$406.6K
YoY Change	-23.41%	-27.03%	-27.03%
SHAREHOLDERS EQUITY
Retained Earnings	-$49.27M	-$48.13M
YoY Change	16.96%	21.16%
Common Stock	$308.00	$210.00
YoY Change	-85.15%	-89.81%
Preferred Stock
YoY Change
Treasury Stock (at cost)	$398.0K	$398.0K
YoY Change	27.89%
Treasury Stock Shares
Shareholders Equity	$6.842M	$6.100M	$6.100M
YoY Change
Total Liabilities & Shareholders Equity	$6.425M	$6.507M	$6.507M
YoY Change	-43.1%	-50.38%	-50.38%

Cashflow Statement

Concept	2024 Q1	2023 Q4	2023
OPERATING ACTIVITIES
Net Income	-$1.138M	-$1.354M	-$8.405M
YoY Change	-52.58%	-61.69%	-30.76%
Depreciation, Depletion And Amortization	$5.782K	$8.250K	$28.94K
YoY Change	0.03%	-86.31%	-77.3%
Cash From Operating Activities	-$1.477M	-$1.370M	-$6.529M
YoY Change	-16.05%	-10.54%	-10.05%
INVESTING ACTIVITIES
Capital Expenditures		$0.00	$49.49K
YoY Change		-100.0%	11.28%
Acquisitions
YoY Change
Other Investing Activities	-$648.5K	$1.664M	$6.210M
YoY Change	-159.19%	-152.0%	-155.63%
Cash From Investing Activities	-$648.4K	$1.664M	$6.161M
YoY Change	-159.19%	-156.08%	-154.96%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net			-$397.0K
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	$1.421M	0.000	-398.3K
YoY Change	-554.66%	-100.0%	-35916.55%
NET CHANGE
Cash From Operating Activities	-$1.477M	-1.370M	-6.529M
Cash From Investing Activities	-$648.4K	1.664M	6.161M
Cash From Financing Activities	$1.421M	0.000	-398.3K
Net Change In Cash	-$704.9K	294.3K	-766.6K
YoY Change	-27.82%	-106.54%	-95.85%
FREE CASH FLOW
Cash From Operating Activities	-$1.477M	-$1.370M	-$6.529M
Capital Expenditures		$0.00	$49.49K
Free Cash Flow		-$1.370M	-$6.579M
YoY Change		5.53%	-9.92%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2023Q4	dats	Digital Currencies And Other Digital Assets DigitalCurrenciesAndOtherDigitalAssets		usd
CY2022	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-6.04
CY2022	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	2010427	shares
CY2023	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	2028584	shares
CY2023	dei	Entity Filer Category EntityFilerCategory	Non-accelerated Filer
CY2022Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		usd
CY2023Q4	us-gaap	Preferred Stock Value PreferredStockValue		usd
CY2022Q4	us-gaap	Preferred Stock Value PreferredStockValue		usd
CY2023Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		usd
CY2022	us-gaap	Foreign Currency Transaction Gain Loss Before Tax ForeignCurrencyTransactionGainLossBeforeTax		usd
CY2022	us-gaap	Variable Interest Entity Initial Consolidation Gain Or Loss VariableInterestEntityInitialConsolidationGainOrLoss		usd
CY2023	dei	Document Type DocumentType	10-K
CY2023	dei	Document Annual Report DocumentAnnualReport	true
CY2023	dei	Document Period End Date DocumentPeriodEndDate	2023-12-31
CY2023	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
CY2023	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2023
CY2023	dei	Document Transition Report DocumentTransitionReport	false
CY2023	dei	Entity File Number EntityFileNumber	001-40729
CY2023	dei	Entity Registrant Name EntityRegistrantName	DATCHAT, INC.
CY2023	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	NV
CY2023	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	47-2502264
CY2023	dei	Entity Address Address Line1 EntityAddressAddressLine1	204 Neilson Street
CY2023	dei	Entity Address City Or Town EntityAddressCityOrTown	New Brunswick
CY2023	dei	Entity Address State Or Province EntityAddressStateOrProvince	NJ
CY2023	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	08901
CY2023	dei	City Area Code CityAreaCode	(732)
CY2023	dei	Local Phone Number LocalPhoneNumber	374-3529
CY2023	dei	Entity Well Known Seasoned Issuer EntityWellKnownSeasonedIssuer	No
CY2023	dei	Entity Voluntary Filers EntityVoluntaryFilers	No
CY2023	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
CY2023	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
CY2023	dei	Entity Small Business EntitySmallBusiness	true
CY2023	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	true
CY2023	dei	Entity Ex Transition Period EntityExTransitionPeriod	false
CY2023	dei	Icfr Auditor Attestation Flag IcfrAuditorAttestationFlag	false
CY2023	dei	Document Fin Stmt Error Correction Flag DocumentFinStmtErrorCorrectionFlag	false
CY2023	dei	Entity Shell Company EntityShellCompany	false
CY2023Q2	dei	Entity Public Float EntityPublicFloat	1797613	usd
CY2024Q1	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	3009329	shares
CY2023Q4	ecd	Non Rule10b51 Arr Adopted Flag NonRule10b51ArrAdoptedFlag	false
CY2023Q4	ecd	Rule10b51 Arr Adopted Flag Rule10b51ArrAdoptedFlag	false
CY2023Q4	ecd	Non Rule10b51 Arr Trmntd Flag NonRule10b51ArrTrmntdFlag	false
CY2023Q4	ecd	Rule10b51 Arr Trmntd Flag Rule10b51ArrTrmntdFlag	false
CY2023	dei	Auditor Firm AuditorFirmId	106
CY2023	dei	Auditor Name AuditorName	SALBERG & COMPANY, P.A.
CY2023	dei	Auditor Location AuditorLocation	Boca Raton, Florida
CY2023Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	953362	usd
CY2022Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	1732956	usd
CY2023Q4	us-gaap	Short Term Investments ShortTermInvestments	5236781	usd
CY2022Q4	us-gaap	Short Term Investments ShortTermInvestments	11007997	usd
CY2023Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	183	usd
CY2022Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	384	usd
CY2023Q4	us-gaap	Prepaid Expense Current PrepaidExpenseCurrent	185675	usd
CY2022Q4	us-gaap	Prepaid Expense Current PrepaidExpenseCurrent	134752	usd
CY2023Q4	us-gaap	Assets Current AssetsCurrent	6376001	usd
CY2022Q4	us-gaap	Assets Current AssetsCurrent	12876089	usd
CY2023Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	56565	usd
CY2022Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	79694	usd
CY2023	dats	Professional And Consulting Expenses ProfessionalAndConsultingExpenses	1324640	usd
CY2022	dats	Professional And Consulting Expenses ProfessionalAndConsultingExpenses	2285312	usd
CY2023	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	1351415	usd
CY2022	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	514957	usd
CY2023	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	892972	usd
CY2022Q4	dats	Digital Currencies And Other Digital Assets DigitalCurrenciesAndOtherDigitalAssets	23381	usd
CY2023Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	73977	usd
CY2022Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	134526	usd
CY2023Q4	us-gaap	Other Assets OtherAssets	130542	usd
CY2022Q4	us-gaap	Other Assets OtherAssets	237601	usd
CY2023Q4	us-gaap	Assets Assets	6506543	usd
CY2022Q4	us-gaap	Assets Assets	13113690	usd
CY2023Q4	us-gaap	Accounts Payable And Accrued Liabilities Current AccountsPayableAndAccruedLiabilitiesCurrent	322762	usd
CY2022Q4	us-gaap	Accounts Payable And Accrued Liabilities Current AccountsPayableAndAccruedLiabilitiesCurrent	404600	usd
CY2023Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	83674	usd
CY2022Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	67338	usd
CY2023Q4	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	118	usd
CY2022Q4	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	186	usd
CY2023Q4	us-gaap	Liabilities Current LiabilitiesCurrent	406554	usd
CY2022Q4	us-gaap	Liabilities Current LiabilitiesCurrent	473439	usd
CY2022Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	83675	usd
CY2022Q4	us-gaap	Liabilities Noncurrent LiabilitiesNoncurrent	83675	usd
CY2023Q4	us-gaap	Liabilities Liabilities	406554	usd
CY2022Q4	us-gaap	Liabilities Liabilities	557114	usd
CY2023Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.0001
CY2022Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.0001
CY2023Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	20000000	shares
CY2022Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	20000000	shares
CY2023Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.0001
CY2022Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.0001
CY2023Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	180000000	shares
CY2022Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	180000000	shares
CY2023Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	2103321	shares
CY2022Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	2059717	shares
CY2023Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	2036376	shares
CY2022Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	2059717	shares
CY2023Q4	us-gaap	Common Stock Value CommonStockValue	210	usd
CY2022Q4	us-gaap	Common Stock Value CommonStockValue	206	usd
CY2023Q4	dats	Common Stock To Be Issued CommonStockToBeIssued	139	shares
CY2022Q4	dats	Common Stock To Be Issued CommonStockToBeIssued	139	shares
CY2023Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	54597083	usd
CY2022Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	52285488	usd
CY2023Q4	us-gaap	Treasury Stock Common Shares TreasuryStockCommonShares	66945	shares
CY2023Q4	us-gaap	Treasury Stock Value TreasuryStockValue	397969	usd
CY2023Q4	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	34553	usd
CY2023Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-48134088	usd
CY2022Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-39729118	usd
CY2023Q4	us-gaap	Stockholders Equity StockholdersEquity	6099989	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	12556576	usd
CY2023Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	6506543	usd
CY2022Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	13113690	usd
CY2023	us-gaap	Revenues Revenues	672	usd
CY2022	us-gaap	Revenues Revenues	46214	usd
CY2023	dats	Compensation And Related Expenses CompensationAndRelatedExpenses	4760180	usd
CY2022	dats	Compensation And Related Expenses CompensationAndRelatedExpenses	6551776	usd
CY2023	us-gaap	Marketing And Advertising Expense MarketingAndAdvertisingExpense	388444	usd
CY2022	us-gaap	Marketing And Advertising Expense MarketingAndAdvertisingExpense	828736	usd
CY2022	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	991882	usd
CY2023	us-gaap	Impairment Of Intangible Assets Finitelived ImpairmentOfIntangibleAssetsFinitelived	43671	usd
CY2022	us-gaap	Impairment Of Intangible Assets Finitelived ImpairmentOfIntangibleAssetsFinitelived	981000	usd
CY2023	us-gaap	Other Asset Impairment Charges OtherAssetImpairmentCharges	23381	usd
CY2022	us-gaap	Other Asset Impairment Charges OtherAssetImpairmentCharges	119276	usd
CY2023	us-gaap	Operating Expenses OperatingExpenses	8784703	usd
CY2022	us-gaap	Operating Expenses OperatingExpenses	12272939	usd
CY2023	us-gaap	Operating Income Loss OperatingIncomeLoss	-8784031	usd
CY2022	us-gaap	Operating Income Loss OperatingIncomeLoss	-12226725	usd
CY2023	us-gaap	Investment Income Interest InvestmentIncomeInterest	9281	usd
CY2022	us-gaap	Investment Income Interest InvestmentIncomeInterest	12305	usd
CY2023	us-gaap	Variable Interest Entity Initial Consolidation Gain Or Loss VariableInterestEntityInitialConsolidationGainOrLoss	42737	usd
CY2023	us-gaap	Foreign Currency Transaction Gain Loss Before Tax ForeignCurrencyTransactionGainLossBeforeTax	-102	usd
CY2023	dats	Realized Gain On Shortterm Investments RealizedGainOnShorttermInvestments	327145	usd
CY2022	dats	Realized Gain On Shortterm Investments RealizedGainOnShorttermInvestments	28176	usd
CY2022	us-gaap	Unrealized Gain Loss On Investments UnrealizedGainLossOnInvestments	47672	usd
CY2023	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	379061	usd
CY2022	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	88153	usd
CY2023	us-gaap	Net Income Loss NetIncomeLoss	-8404970	usd
CY2022	us-gaap	Net Income Loss NetIncomeLoss	-12138572	usd
CY2023	us-gaap	Net Income Loss NetIncomeLoss	-8404970	usd
CY2022	us-gaap	Net Income Loss NetIncomeLoss	-12138572	usd
CY2023	dats	Unrealized Gain On Shortterm Investments UnrealizedGainOnShorttermInvestments	47518	usd
CY2023	dats	Unrealized Foreign Currency Translation Gain UnrealizedForeignCurrencyTranslationGain	-12965	usd
CY2023	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-8370417	usd
CY2022	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-12138572	usd
CY2023	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-4.14
CY2022	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-6.04
CY2023	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	2028584	shares
CY2022	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	2010427	shares
CY2021Q4	us-gaap	Stockholders Equity StockholdersEquity	20084014	usd
CY2022	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	3173401	usd
CY2022	us-gaap	Adjustments To Additional Paid In Capital Share Based Compensation Stock Options Requisite Service Period Recognition AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition	347733	usd
CY2022	us-gaap	Stock Issued During Period Value Acquisitions StockIssuedDuringPeriodValueAcquisitions	1090000	usd
CY2022	us-gaap	Net Income Loss NetIncomeLoss	-12138572	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	12556576	usd
CY2023	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	2002777	usd
CY2023	us-gaap	Adjustments To Additional Paid In Capital Share Based Compensation Stock Options Requisite Service Period Recognition AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition	108022	usd
CY2023	us-gaap	Stock Issued During Period Value Issued For Services StockIssuedDuringPeriodValueIssuedForServices	200000	usd
CY2023	dats	Sale Of Series B Preferred Stock SaleOfSeriesBPreferredStock	1000	usd
CY2023	us-gaap	Stock Issued During Period Value Treasury Stock Reissued StockIssuedDuringPeriodValueTreasuryStockReissued	-397969	usd
CY2023	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	34553	usd
CY2023	us-gaap	Net Income Loss NetIncomeLoss	-8404970	usd
CY2023Q4	us-gaap	Stockholders Equity StockholdersEquity	6099989	usd
CY2023	us-gaap	Net Income Loss NetIncomeLoss	-8404970	usd
CY2022	us-gaap	Net Income Loss NetIncomeLoss	-12138572	usd
CY2023	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	28943	usd
CY2022	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	127501	usd
CY2023	us-gaap	Finance Lease Right Of Use Asset Amortization FinanceLeaseRightOfUseAssetAmortization	60549	usd
CY2022	us-gaap	Finance Lease Right Of Use Asset Amortization FinanceLeaseRightOfUseAssetAmortization	49783	usd
CY2023	us-gaap	Share Based Compensation ShareBasedCompensation	2002777	usd
CY2022	us-gaap	Share Based Compensation ShareBasedCompensation	3173401	usd
CY2023	dats	Stockbased Professional Fees StockbasedProfessionalFees	251302	usd
CY2022	dats	Stockbased Professional Fees StockbasedProfessionalFees	347733	usd
CY2023	dats	Gain From Initial Consolidation Of Variable Interest Entities GainFromInitialConsolidationOfVariableInterestEntities	42737	usd
CY2023	dats	Impairment Loss On Property And Equipment And Intangible Assets ImpairmentLossOnPropertyAndEquipmentAndIntangibleAssets	43671	usd
CY2022	dats	Impairment Loss On Property And Equipment And Intangible Assets ImpairmentLossOnPropertyAndEquipmentAndIntangibleAssets	981000	usd
CY2023	us-gaap	Asset Impairment Charges AssetImpairmentCharges	23381	usd
CY2022	us-gaap	Asset Impairment Charges AssetImpairmentCharges	119276	usd
CY2022	us-gaap	Noncash Contribution Expense NoncashContributionExpense	13739	usd
CY2022	us-gaap	Other Noncash Income OtherNoncashIncome	36394	usd
CY2023	us-gaap	Realized Investment Gains Losses RealizedInvestmentGainsLosses	327145	usd
CY2022	us-gaap	Realized Investment Gains Losses RealizedInvestmentGainsLosses	28176	usd
CY2022	us-gaap	Unrealized Gain Loss On Investments UnrealizedGainLossOnInvestments	47672	usd
CY2023	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-201	usd
CY2022	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	106	usd
CY2023	us-gaap	Increase Decrease In Prepaid Expense IncreaseDecreaseInPrepaidExpense	-5797	usd
CY2022	us-gaap	Increase Decrease In Prepaid Expense IncreaseDecreaseInPrepaidExpense	-242221	usd
CY2023	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	-103639	usd
CY2022	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	61	usd
CY2023	us-gaap	Increase Decrease In Contract With Customer Liability IncreaseDecreaseInContractWithCustomerLiability	-68	usd
CY2022	us-gaap	Increase Decrease In Contract With Customer Liability IncreaseDecreaseInContractWithCustomerLiability	-8664	usd
CY2023	us-gaap	Increase Decrease In Operating Lease Liability IncreaseDecreaseInOperatingLeaseLiability	-67339	usd
CY2022	us-gaap	Increase Decrease In Operating Lease Liability IncreaseDecreaseInOperatingLeaseLiability	-53896	usd
CY2023	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-6529277	usd
CY2022	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-7258765	usd
CY2023	us-gaap	Proceeds From Sale Of Short Term Investments ProceedsFromSaleOfShortTermInvestments	14745000	usd
CY2022	us-gaap	Proceeds From Sale Of Short Term Investments ProceedsFromSaleOfShortTermInvestments	9910000	usd
CY2023	us-gaap	Payments To Acquire Short Term Investments PaymentsToAcquireShortTermInvestments	8599121	usd
CY2022	us-gaap	Payments To Acquire Short Term Investments PaymentsToAcquireShortTermInvestments	20842149	usd
CY2023	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	49485	usd
CY2022	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	44475	usd
CY2023	dats	Increase In Cash From Consolidation Of Variable Interest Entities IncreaseInCashFromConsolidationOfVariableInterestEntities	64538	usd
CY2022	us-gaap	Proceeds From Sale Of Productive Assets ProceedsFromSaleOfProductiveAssets	743	usd
CY2022	us-gaap	Payments To Acquire Intangible Assets PaymentsToAcquireIntangibleAssets	233245	usd
CY2023	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	6160932	usd
CY2022	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-11209126	usd
CY2022	us-gaap	Proceeds From Repayments Of Related Party Debt ProceedsFromRepaymentsOfRelatedPartyDebt	20294	usd
CY2023	us-gaap	Repayments Of Notes Payable RepaymentsOfNotesPayable	1315	usd
CY2022	us-gaap	Repayments Of Notes Payable RepaymentsOfNotesPayable	19182	usd
CY2023	us-gaap	Proceeds From Issuance Of Preferred Stock And Preference Stock ProceedsFromIssuanceOfPreferredStockAndPreferenceStock	1000	usd
CY2023	dats	Paymentsto Treasury Stock PaymentstoTreasuryStock	397969	usd
CY2023	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-398284	usd
CY2022	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	1112	usd
CY2023	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect	-766629	usd
CY2022	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect	-18466779	usd
CY2023	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	-12965	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	1732956	usd
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	20199735	usd
CY2023Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	953362	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	1732956	usd
CY2022	dats	Intangible Assets Used To Pay Accounts Payable IntangibleAssetsUsedToPayAccountsPayable	112500	usd
CY2023	us-gaap	Stock Issued1 StockIssued1	200000	usd
CY2022	dats	Issuance Of Common Shares For Intangible Assets IssuanceOfCommonSharesForIntangibleAssets	1090000	usd
CY2023	dats	Increase In Shortterm Investments And Accumulated Other Comprehensive Gain IncreaseInShorttermInvestmentsAndAccumulatedOtherComprehensiveGain	47518000000	usd
CY2023Q1	us-gaap	Common Stock Value Outstanding CommonStockValueOutstanding	800	usd
CY2023Q1	dats	Percentage Of Share Issued And Outstanding PercentageOfShareIssuedAndOutstanding	0.40	pure
CY2023Q4	dats	Additonal Common Stock AdditonalCommonStock	12000000	shares
CY2023Q4	us-gaap	Other General Expense OtherGeneralExpense	500000	usd
CY2023	dats	Parent Company Owned Shares Percentage ParentCompanyOwnedSharesPercentage	0.75	pure
CY2022Q2	dats	Number Of Acquisition Share NumberOfAcquisitionShare	100000	shares
CY2023Q3	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.0001
CY2023Q1	us-gaap	Variable Interest Entity Initial Consolidation Gain Or Loss VariableInterestEntityInitialConsolidationGainOrLoss	42737	usd
CY2023	us-gaap	Net Income Loss NetIncomeLoss	-8404970	usd
CY2023	us-gaap	Net Cash Provided By Used In Discontinued Operations NetCashProvidedByUsedInDiscontinuedOperations	6529277	usd
CY2023Q4	dats	Accumulated Deficit For The Period AccumulatedDeficitForThePeriod	48134088	usd
CY2023Q4	us-gaap	Capital Capital	5969447	usd
CY2023Q4	us-gaap	Investments And Cash InvestmentsAndCash	953362	usd
CY2023Q4	us-gaap	Other Short Term Investments OtherShortTermInvestments	5236781	usd
CY2023	us-gaap	Proceeds From Issuance Initial Public Offering ProceedsFromIssuanceInitialPublicOffering	382972	usd
CY2023	dats	Purchase Of Company Common Stock PurchaseOfCompanyCommonStock	590000	shares
CY2023Q4	dats	Net Proceeds NetProceeds	1437940	usd
CY2022	dats	Commonstockequivalents Commonstockequivalents	227805	shares
CY2023	us-gaap	Use Of Estimates UseOfEstimates	<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span style="text-decoration:underline">Use of estimates</span></b></span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The preparation of the financial statements in conformity with accounting principles generally accepted in the U.S. requires management to make estimates and assumptions that affect the reported amounts of assets, liabilities, revenues, expenses, and the related disclosures at the date of the consolidated financial statements and during the reporting period. Actual results could materially differ from these estimates. Significant estimates include assumptions used in assessing impairment of long-term assets, the valuation of intangible assets, the valuation of digital currencies and other digital assets, the valuation of lease liabilities and related right of use assets, the valuation of short-term investments, the valuation of deferred tax assets, the fair value of assets and liabilities of VIE’s on the initial VIE consolidation date, and the fair value of non-cash equity transactions.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p>
CY2023	us-gaap	Gain Loss On Investments GainLossOnInvestments	34553	usd
CY2022	us-gaap	Unrealized Gain Loss On Investments UnrealizedGainLossOnInvestments	47672	usd
CY2023Q4	us-gaap	Accounts Receivable Net AccountsReceivableNet	183	usd
CY2022Q4	us-gaap	Accounts Receivable Net AccountsReceivableNet	384	usd
CY2023	us-gaap	Impairment Of Leasehold ImpairmentOfLeasehold	23381	usd
CY2022	us-gaap	Impairment Of Leasehold ImpairmentOfLeasehold	119276	usd
CY2023	us-gaap	Revenues Revenues	672	usd
CY2022	us-gaap	Revenues Revenues	46214	usd
CY2023	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	1351415	usd
CY2022	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	514957	usd
CY2023	us-gaap	Advertising Expense AdvertisingExpense	388444	usd
CY2022	us-gaap	Advertising Expense AdvertisingExpense	828736	usd
CY2023	dats	Largest Amount Of Tax Benefit LargestAmountOfTaxBenefit	0.50	pure
CY2023	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	-12965	usd
CY2023	us-gaap	Description Of Foreign Currency Exposure DescriptionOfForeignCurrencyExposure	For Metabizz SAS, which is located in Columbia, asset and liability accounts on December 31, 2023 were translated at 0.0002582 COP to $1.00, which was the exchange rate on the balance sheet date, and results of operations and cash flows are translated at the average exchange rates during the period of 0.00023415 COP to $1.00.
CY2023	dats	Common Stock Warrants CommonStockWarrants	67385	shares
CY2022	dats	Common Stock Warrants CommonStockWarrants	67385	shares
CY2023	dats	Common Stock Options CommonStockOptions	158670	shares
CY2022	dats	Common Stock Options CommonStockOptions	160420	shares
CY2023	dats	Commonstockequivalents Commonstockequivalents	226055	shares
CY2023Q4	us-gaap	Investment Owned At Cost InvestmentOwnedAtCost	5189263	usd
CY2023	dats	Unrealized Gains Loss On Investments UnrealizedGainsLossOnInvestments	47518	usd
CY2023Q4	us-gaap	Investment Owned At Fair Value InvestmentOwnedAtFairValue	5236781	usd
CY2022Q4	us-gaap	Investment Owned At Cost InvestmentOwnedAtCost	10960325	usd
CY2022	dats	Unrealized Gains Loss On Investments UnrealizedGainsLossOnInvestments	47672	usd
CY2022Q4	us-gaap	Investment Owned At Fair Value InvestmentOwnedAtFairValue	11007997	usd
CY2019Q1	dats	Operating Lease Monthly Base Rent OperatingLeaseMonthlyBaseRent	2567	usd
CY2022Q4	dats	Operating Lease New Monthly Base Rent OperatingLeaseNewMonthlyBaseRent	7156	usd
CY2023Q4	dats	Annual Increase Percentage In Lease Agreement AnnualIncreasePercentageInLeaseAgreement	0.03	pure
CY2023	us-gaap	Payments For Rent PaymentsForRent	95310	usd
CY2022	us-gaap	Payments For Rent PaymentsForRent	94924	usd
CY2023Q4	us-gaap	Lessee Operating Lease Remaining Lease Term LesseeOperatingLeaseRemainingLeaseTerm	P12M
CY2023	us-gaap	Subordinated Borrowing Interest Rate SubordinatedBorrowingInterestRate	0.18	pure
CY2023Q4	dats	Rightof Use Office Lease RightofUseOfficeLease	198898	usd
CY2022Q4	dats	Rightof Use Office Lease RightofUseOfficeLease	198898	usd
CY2023Q4	dats	Operating Lease Right Of Use Asset Accumulated Amortization OperatingLeaseRightOfUseAssetAccumulatedAmortization	124921	usd
CY2022Q4	dats	Operating Lease Right Of Use Asset Accumulated Amortization OperatingLeaseRightOfUseAssetAccumulatedAmortization	64372	usd
CY2023Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	73977	usd
CY2022Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	134526	usd
CY2023Q4	dats	Rightof Use Office Lease RightofUseOfficeLease	198898	usd
CY2022Q4	dats	Rightof Use Office Lease RightofUseOfficeLease	198898	usd
CY2023Q4	dats	Reduction Of Lease Liability ReductionOfLeaseLiability	-115224	usd
CY2022	us-gaap	Other Income OtherIncome	51500	usd
CY2023Q3	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.0001
CY2022Q4	dats	Reduction Of Lease Liability ReductionOfLeaseLiability	-47885	usd
CY2023Q4	us-gaap	Operating Lease Liability OperatingLeaseLiability	83674	usd
CY2022Q4	us-gaap	Operating Lease Liability OperatingLeaseLiability	151013	usd
CY2023Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	83674	usd
CY2022Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	67338	usd
CY2022Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	83675	usd
CY2023Q4	us-gaap	Lessee Operating Lease Liability Payments Due Next Twelve Months LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths	92100	usd
CY2023Q4	us-gaap	Lessee Operating Lease Liability Payments Due LesseeOperatingLeaseLiabilityPaymentsDue	92100	usd
CY2023Q4	us-gaap	Lessee Operating Lease Liability Undiscounted Excess Amount LesseeOperatingLeaseLiabilityUndiscountedExcessAmount	8426	usd
CY2023Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	83674	usd
CY2022Q2	us-gaap	Stock Issued During Period Shares Acquisitions StockIssuedDuringPeriodSharesAcquisitions	100000	shares
CY2022Q2	dats	Issuance Of Common Shares For Intangible Assets IssuanceOfCommonSharesForIntangibleAssets	1090000	usd
CY2022Q2	dats	Business Acquisitions Share Price BusinessAcquisitionsSharePrice	10.9
CY2022Q2	us-gaap	Finite Lived Intangible Assets Remaining Amortization Period1 FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1	P5Y
CY2022Q4	us-gaap	Finite Lived Patents Gross FiniteLivedPatentsGross	1090000	usd
CY2022Q4	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	109000	usd
CY2022	us-gaap	Impairment Of Intangible Assets Finitelived ImpairmentOfIntangibleAssetsFinitelived	981000	usd
CY2022	us-gaap	Impairment Of Intangible Assets Finitelived ImpairmentOfIntangibleAssetsFinitelived	981000	usd
CY2023	us-gaap	Repayments Of Debt RepaymentsOfDebt	1315	usd
CY2022Q3	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	185600	usd
CY2023	us-gaap	Other Income OtherIncome	72000	usd
CY2023Q3	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.0001
CY2023Q3	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	1000000	shares
CY2023Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.0001
CY2023Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	20000000	shares
CY2023Q4	us-gaap	Capital Units Authorized CapitalUnitsAuthorized	200000000	shares
CY2021Q3	us-gaap	Common Stock Capital Shares Reserved For Future Issuance CommonStockCapitalSharesReservedForFutureIssuance	200000	shares
CY2023	us-gaap	Stockholders Equity Note Stock Split StockholdersEquityNoteStockSplit	In August 2016, the Company designated one share of Series A Preferred Stock, par value $0.0001 per share (the “Series A Preferred Stock”), which has a stated value equal to $1.00 as may be adjusted for any stock dividends, combinations or splits. Each one (1) share of the Series A Preferred Stock shall have voting rights equal to (x) the total issued and outstanding Common Stock eligible to vote at the time of the respective vote divided by (y) forty-nine one hundredths (0.49) minus (z) the total issued and outstanding Common Stock eligible to vote at the time of the respective vote.
CY2023	us-gaap	Preferred Stock Voting Rights PreferredStockVotingRights	10
CY2023Q4	us-gaap	Preferred Stock Redemption Amount PreferredStockRedemptionAmount	10	usd
CY2023	dats	Aggregate Shares AggregateShares	100000	shares
CY2023Q4	us-gaap	Business Acquisition Cost Of Acquired Entity Transaction Costs BusinessAcquisitionCostOfAcquiredEntityTransactionCosts	1090000	usd
CY2023Q1	us-gaap	Stock Repurchase Program Authorized Amount1 StockRepurchaseProgramAuthorizedAmount1	2000000	usd
CY2021Q1	dats	Common Stock Shares Consideration CommonStockSharesConsideration	10000	shares
CY2021Q1	dats	Common Share Fair Values CommonShareFairValues	400000	usd
CY2021Q1	dats	Common Share Fair Value CommonShareFairValue	40
CY2022	dats	Stock Based Consulting Fees StockBasedConsultingFees	50000	usd
CY2023Q1	dats	Restricted Common Shares Issued RestrictedCommonSharesIssued	14300	shares
CY2023Q1	dats	Common Share Fair Values CommonShareFairValues	100000	usd
CY2023Q1	dats	Common Share Fair Value CommonShareFairValue	6.99
CY2023Q3	us-gaap	Prepaid Expense And Other Assets PrepaidExpenseAndOtherAssets	56720	usd
CY2022Q1	dats	Stock Option Exercisable Term StockOptionExercisableTerm	P5Y
CY2022Q1	us-gaap	Sharebased Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Exercisable Options Weighted Average Exercise Price1 SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1	40
CY2022Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Number Of Shares Available For Grant ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant	32500	shares
CY2022Q3	us-gaap	Sharebased Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Exercisable Options Weighted Average Remaining Contractual Term2 SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageRemainingContractualTerm2	P5Y
CY2022Q3	us-gaap	Sharebased Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Exercisable Options Weighted Average Exercise Price1 SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1	40
CY2023	dats	Stock Options At Fair Value StockOptionsAtFairValue	751681	usd
CY2023Q1	us-gaap	Sharebased Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Exercisable Options Weighted Average Remaining Contractual Term2 SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageRemainingContractualTerm2	P5Y
CY2023Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Number Of Shares Available For Grant ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant	21500	shares
CY2023Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Number Of Shares Available For Grant ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant	10000	shares
CY2023Q3	us-gaap	Sharebased Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Exercisable Options Weighted Average Remaining Contractual Term2 SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageRemainingContractualTerm2	P5Y
CY2023Q3	us-gaap	Sharebased Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Exercisable Options Weighted Average Exercise Price1 SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1	15
CY2023	us-gaap	Stock Option Plan Expense StockOptionPlanExpense	185628	usd
CY2023	us-gaap	Stock Option Exercise Price Increase StockOptionExercisePriceIncrease	4.76
CY2023	us-gaap	Stock Issued During Period Shares Share Based Compensation Forfeited StockIssuedDuringPeriodSharesShareBasedCompensationForfeited	33775	shares
CY2023Q4	us-gaap	Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Stock Options EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions	133190	usd
CY2023	us-gaap	Professional Fees ProfessionalFees	26144	usd
CY2023	dats	Stock Based Expense StockBasedExpense	2110799	usd
CY2023	dats	Remaining Balance Of Stock Based Consulting RemainingBalanceOfStockBasedConsulting	2002777	usd
CY2022	us-gaap	Stock Option Plan Expense StockOptionPlanExpense	3173401	usd
CY2023	dats	Stock Issued During Period Shares Issued For Service StockIssuedDuringPeriodSharesIssuedForService	94606	usd
CY2023	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Remaining Contractual Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1	P0Y8M4D
CY2023	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1	P3Y
CY2023Q4	dats	Aggregate Intrinsic Value Stock Options Outstanding AggregateIntrinsicValueStockOptionsOutstanding	0	usd
CY2022	us-gaap	Proceeds From Warrant Exercises ProceedsFromWarrantExercises	6250	usd
CY2022	us-gaap	Payments Of Stock Issuance Costs PaymentsOfStockIssuanceCosts	44252	usd
CY2021Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Number ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber	73635	shares
CY2021Q4	dats	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageExercisePrice	45.9
CY2021Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Outstanding Weighted Average Remaining Contractual Terms ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageRemainingContractualTerms	P4Y3M18D
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Forfeited In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod	6250	shares
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Number ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber	67385	shares
CY2022Q4	dats	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageExercisePrice	49.8
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Outstanding Weighted Average Remaining Contractual Terms ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageRemainingContractualTerms	P3Y7M24D
CY2023Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Number ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber	67385	shares
CY2023Q4	dats	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageExercisePrice	49.8
CY2023	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Outstanding Weighted Average Remaining Contractual Terms ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageRemainingContractualTerms	P2Y7M24D
CY2023Q4	dats	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Exercisable Number ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsExercisableNumber	67385	shares
CY2023Q4	dats	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Exercisable Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedExercisableWeightedAverageExercisePrice	49.8
CY2023	dats	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Exercisable Outstanding Weighted Average Remaining Contractual Terms ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsExercisableOutstandingWeightedAverageRemainingContractualTerms	P2Y7M24D
CY2023Q4	us-gaap	Warrants And Rights Outstanding WarrantsAndRightsOutstanding	0	usd
CY2021Q3	us-gaap	Accrued Salaries Current And Noncurrent AccruedSalariesCurrentAndNoncurrent	450000	usd
CY2021Q3	us-gaap	Accrued Bonuses Current And Noncurrent AccruedBonusesCurrentAndNoncurrent	350000	usd
CY2023Q4	us-gaap	Compensating Balance Amount CompensatingBalanceAmount	300000	usd
CY2022Q4	us-gaap	Compensating Balance Amount CompensatingBalanceAmount	0	usd
CY2023Q4	us-gaap	Operating Loss Carryforwards OperatingLossCarryforwards	26782280	usd
CY2023Q4	srt	Financing Receivable Allowance For Credit Loss To Nonaccrual Percent FinancingReceivableAllowanceForCreditLossToNonaccrualPercent	1	pure
CY2023	us-gaap	Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate	-1765044	usd
CY2022	us-gaap	Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate	-2549100	usd
CY2023	us-gaap	Income Tax Reconciliation State And Local Income Taxes IncomeTaxReconciliationStateAndLocalIncomeTaxes	-420248	usd
CY2022	us-gaap	Income Tax Reconciliation State And Local Income Taxes IncomeTaxReconciliationStateAndLocalIncomeTaxes	-606929	usd
CY2023	us-gaap	Income Tax Reconciliation Nondeductible Expense IncomeTaxReconciliationNondeductibleExpense	587344	usd
CY2023	us-gaap	Unrealized Gain Loss On Investments UnrealizedGainLossOnInvestments		usd
CY2022Q4	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill		usd
CY2022	us-gaap	Income Tax Reconciliation Nondeductible Expense IncomeTaxReconciliationNondeductibleExpense	1170555	usd
CY2023	us-gaap	Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance	1597948	usd
CY2022	us-gaap	Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance	1985474	usd
CY2023Q4	us-gaap	Deferred Tax Assets Operating Loss Carryforwards Domestic DeferredTaxAssetsOperatingLossCarryforwardsDomestic	6963393	usd
CY2022Q4	us-gaap	Deferred Tax Assets Operating Loss Carryforwards Domestic DeferredTaxAssetsOperatingLossCarryforwardsDomestic	5365445	usd
CY2023Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	6963393	usd
CY2022Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	5365445	usd
CY2023Q4	us-gaap	Deferred Tax Assets Operating Loss Carryforwards Not Subject To Expiration DeferredTaxAssetsOperatingLossCarryforwardsNotSubjectToExpiration	26782280	usd
CY2023Q4	us-gaap	Deferred Tax Assets Operating Loss Carryforwards Subject To Expiration DeferredTaxAssetsOperatingLossCarryforwardsSubjectToExpiration	1403306	usd
CY2023Q4	us-gaap	Deferred Tax Assets Operating Loss Carryforwards DeferredTaxAssetsOperatingLossCarryforwards	25378974	usd
CY2023Q4	us-gaap	Income Tax Examination Increase Decrease In Liability From Prior Year IncomeTaxExaminationIncreaseDecreaseInLiabilityFromPriorYear	1597948	usd
CY2022Q4	us-gaap	Income Tax Examination Increase Decrease In Liability From Prior Year IncomeTaxExaminationIncreaseDecreaseInLiabilityFromPriorYear	1985474	usd
CY2023	us-gaap	Warrant Exercise Price Decrease WarrantExercisePriceDecrease	0.0001
CY2023Q4	dats	Underwriter Shares UnderwriterShares	590000	shares
CY2023	us-gaap	Incremental Common Shares Attributable To Conversion Of Preferred Stock IncrementalCommonSharesAttributableToConversionOfPreferredStock	589981	shares
CY2023Q4	dats	Common Stockvalueone CommonStockvalueone		usd
CY2022Q4	dats	Common Stockvalueone CommonStockvalueone		usd
CY2022Q4	us-gaap	Treasury Stock Value TreasuryStockValue		usd
CY2022Q4	us-gaap	Treasury Stock Common Shares TreasuryStockCommonShares		shares
CY2022Q4	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax		usd
CY2023	us-gaap	Unrealized Gain Loss On Investments UnrealizedGainLossOnInvestments		usd
CY2022	dats	Unrealized Gain On Shortterm Investments UnrealizedGainOnShorttermInvestments		usd
CY2022	dats	Unrealized Foreign Currency Translation Gain UnrealizedForeignCurrencyTranslationGain		usd
CY2023	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-4.14
CY2023	dats	Common Stocks Amount Rounding CommonStocksAmountRounding		usd
CY2022	dats	Gain From Initial Consolidation Of Variable Interest Entities GainFromInitialConsolidationOfVariableInterestEntities		usd
CY2023	us-gaap	Noncash Contribution Expense NoncashContributionExpense		usd
CY2023	us-gaap	Other Noncash Income OtherNoncashIncome		usd
CY2023	us-gaap	Unrealized Gain Loss On Investments UnrealizedGainLossOnInvestments		usd
CY2023	us-gaap	Increase Decrease In Accounts Receivable Related Parties IncreaseDecreaseInAccountsReceivableRelatedParties		usd
CY2022	us-gaap	Increase Decrease In Accounts Receivable Related Parties IncreaseDecreaseInAccountsReceivableRelatedParties		usd
CY2022	dats	Increase In Cash From Consolidation Of Variable Interest Entities IncreaseInCashFromConsolidationOfVariableInterestEntities		usd
CY2023	us-gaap	Payments To Acquire Intangible Assets PaymentsToAcquireIntangibleAssets		usd
CY2023	us-gaap	Proceeds From Repayments Of Related Party Debt ProceedsFromRepaymentsOfRelatedPartyDebt		usd
CY2022	us-gaap	Proceeds From Issuance Of Preferred Stock And Preference Stock ProceedsFromIssuanceOfPreferredStockAndPreferenceStock		usd
CY2022	dats	Paymentsto Treasury Stock PaymentstoTreasuryStock		usd
CY2022	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents		usd
CY2023	us-gaap	Interest Paid Net InterestPaidNet		usd
CY2022	us-gaap	Interest Paid Net InterestPaidNet		usd
CY2023	us-gaap	Income Taxes Paid IncomeTaxesPaid		usd
CY2022	us-gaap	Income Taxes Paid IncomeTaxesPaid		usd
CY2023	dats	Intangible Assets Used To Pay Accounts Payable IntangibleAssetsUsedToPayAccountsPayable		usd
CY2022	us-gaap	Stock Issued1 StockIssued1		usd
CY2023	dats	Issuance Of Common Shares For Intangible Assets IssuanceOfCommonSharesForIntangibleAssets		usd
CY2022	dats	Increase In Shortterm Investments And Accumulated Other Comprehensive Gain IncreaseInShorttermInvestmentsAndAccumulatedOtherComprehensiveGain		usd
CY2023	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate		pure
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate		pure
CY2023	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod		shares
CY2023	dats	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Weighted Average Exercise Price Granted ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageExercisePriceGranted
CY2023	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit		usd
CY2022	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit		usd
CY2023Q4	us-gaap	Deferred Tax Assets Net DeferredTaxAssetsNet		usd
CY2022Q4	us-gaap	Deferred Tax Assets Net DeferredTaxAssetsNet		usd
CY2023	dei	Amendment Flag AmendmentFlag	false
CY2023	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	FY
CY2023	dei	Entity Central Index Key EntityCentralIndexKey	0001648960

Files In Submission

Name	View Source	Status
0001213900-24-027991-index-headers.html	Edgar Link	pending
0001213900-24-027991-index.html	Edgar Link	pending
0001213900-24-027991.txt	Edgar Link	pending
0001213900-24-027991-xbrl.zip	Edgar Link	pending
dats-20231231.xsd	Edgar Link	pending
ea0202433-10k_datchat.htm	Edgar Link	pending
ea020243301ex21-1_datchat.htm	Edgar Link	pending
ea020243301ex23-1_datchat.htm	Edgar Link	pending
ea020243301ex23-2_datchat.htm	Edgar Link	pending
ea020243301ex31-1_datchat.htm	Edgar Link	pending
ea020243301ex31-2_datchat.htm	Edgar Link	pending
ea020243301ex32-1_datchat.htm	Edgar Link	pending
ea020243301ex4-8_datchat.htm	Edgar Link	pending
ea020243301ex97-1_datchat.htm	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
fin_001.jpg	Edgar Link	pending
fin_002.jpg	Edgar Link	pending
fin_003.jpg	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
dats-20231231_cal.xml	Edgar Link	unprocessable
dats-20231231_def.xml	Edgar Link	unprocessable
dats-20231231_lab.xml	Edgar Link	unprocessable
dats-20231231_pre.xml	Edgar Link	unprocessable
FilingSummary.xml	Edgar Link	unprocessable
ea0202433-10k_datchat_htm.xml	Edgar Link	completed
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$DATS
DatChat, Inc. Stock $dats

2024 Q1 Form 10-K Financial Statement

#000121390024027991 Filed on March 29, 2024

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$DATS DatChat, Inc. Stock $dats

2024 Q1 Form 10-K Financial Statement

#000121390024027991 Filed on March 29, 2024

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$DATS
DatChat, Inc. Stock $dats